2,167 results on '"Kim, Dong Joon"'
Search Results
102. The seamless integration of dietary plant-derived natural flavonoids and gut microbiota may ameliorate non-alcoholic fatty liver disease: a network pharmacology analysis
103. The orchestration of Cornus kousa fruit and gut microbiota for anti- obesity via integrated pharmacological analysis based on metabolomics
104. The diagnostic significance of hepatitis C virus antibody levels for chronic hepatitis C virus infection
105. A 2 kW, 8 GHz-Linewidth Yb-Doped Polarization-Maintained Fiber Laser with Quasi-Flat-Top Pseudo Random Binary Sequence Phase Modulation for SBS Suppression
106. Supplementary Table Legend from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
107. Supplemental Figure 3 from The Prolyl Isomerase Pin1 Is a Novel Target of 6,7,4′-Trihydroxyisoflavone for Suppressing Esophageal Cancer Growth
108. Supplementary Table 1 from Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1
109. Supplemental figure legends from Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma
110. Data from The Prolyl Isomerase Pin1 Is a Novel Target of 6,7,4′-Trihydroxyisoflavone for Suppressing Esophageal Cancer Growth
111. Supplemental Figure 2 from The Prolyl Isomerase Pin1 Is a Novel Target of 6,7,4′-Trihydroxyisoflavone for Suppressing Esophageal Cancer Growth
112. Supplemental Figure Legend from The Prolyl Isomerase Pin1 Is a Novel Target of 6,7,4′-Trihydroxyisoflavone for Suppressing Esophageal Cancer Growth
113. Supplementary Table 1 from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
114. Figure S1 from Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma
115. Data from Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma
116. Supplementary Figure 1 from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
117. Supplementary Figure 2 from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
118. Data from (3-Chloroacetyl)-indole, a Novel Allosteric AKT Inhibitor, Suppresses Colon Cancer Growth In Vitro and In Vivo
119. Data from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
120. Supplementary Methods and Figure Legend from Esculetin Suppresses Proliferation of Human Colon Cancer Cells by Directly Targeting β-Catenin
121. Perspective on This Article from Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1
122. Table S1 from Scutellarin Suppresses Patient-Derived Xenograft Tumor Growth by Directly Targeting AKT in Esophageal Squamous Cell Carcinoma
123. Data from Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1
124. Supplementary Methods from Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1
125. Supplementary Table 1 from (3-Chloroacetyl)-indole, a Novel Allosteric AKT Inhibitor, Suppresses Colon Cancer Growth In Vitro and In Vivo
126. Supplementary Figure 1 from Esculetin Suppresses Proliferation of Human Colon Cancer Cells by Directly Targeting β-Catenin
127. Supplementary Figures 1-6 from Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1
128. Supplementary Figure 2 from Esculetin Suppresses Proliferation of Human Colon Cancer Cells by Directly Targeting β-Catenin
129. Supplementary Figure Legends 1-6 from Epigallocatechin-gallate Suppresses Tumorigenesis by Directly Targeting Pin1
130. Supplementary Figure Legend from Direct Targeting of MEK1/2 and RSK2 by Silybin Induces Cell-Cycle Arrest and Inhibits Melanoma Cell Growth
131. Data from Esculetin Suppresses Proliferation of Human Colon Cancer Cells by Directly Targeting β-Catenin
132. Supplemental Figure 1 from The Prolyl Isomerase Pin1 Is a Novel Target of 6,7,4′-Trihydroxyisoflavone for Suppressing Esophageal Cancer Growth
133. 2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
134. Preliminary experience of stent-assisted coiling of wide-necked intracranial aneurysms with a single microcatheter
135. Assistive Technologies for Elderly – Review on Recent Developments in Lower Limb and Back Pain Management
136. A systematic method for tuning the dynamics of electrostatically actuated vibratory gyros
137. Balloon Guide Catheter Is Beneficial in Endovascular Treatment Regardless of Mechanical Recanalization Modality
138. Liver cirrhosis and cancer: comparison of mortality
139. Double inter-internal carotid artery communication through intercavernous anastomosis and posterior communicating artery associated with multiple intracranial artery segmental agenesis/aplasia
140. Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease
141. Supplemental Table S1 from A Novel Cinnamon-Related Natural Product with Pim-1 Inhibitory Activity Inhibits Leukemia and Skin Cancer
142. Supplementary Methods and Materials, Tables 1-4, Figure Legends 1-3 from Functional and Clinical Evidence for NDRG2 as a Candidate Suppressor of Liver Cancer Metastasis
143. Supplementary Figure 3 from Functional and Clinical Evidence for NDRG2 as a Candidate Suppressor of Liver Cancer Metastasis
144. Supplementary Figure 1 from Functional and Clinical Evidence for NDRG2 as a Candidate Suppressor of Liver Cancer Metastasis
145. Data from Novel TOPK Inhibitor HI-TOPK-032 Effectively Suppresses Colon Cancer Growth
146. Supplemental Figure 5 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
147. Data from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
148. Supplemental Table 1 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
149. Supplemental Figure S1 from A Novel Cinnamon-Related Natural Product with Pim-1 Inhibitory Activity Inhibits Leukemia and Skin Cancer
150. Supplemental Figure 2 from Herbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.